Optically Optimizing Anticancer Drugs
December 16, 2014 | Terry Sharrer
While genomics research works to find the drivers of metabolism, which, among other things, determine an individual’s drug tolerance and effectiveness, chemists at the University of Montreal have found that gold nanoparticles can capture methotrexate (used in treating breast cancer) and, with an optical scanner, can calibrate the amount of the drug in a patient’s blood. This device is as accurate as results from traditional laboratory analysis, and resolves in 60 seconds. MORE
Image Credit: University of Montreal and MedicalNewsToday.com